{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:48:35Z","timestamp":1769244515983,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2021 Scientific Research Topics of Heilongjiang Provincial Health and Wellness Committee","award":["20210303030052"],"award-info":[{"award-number":["20210303030052"]}]},{"name":"2021 Heilongjiang Provincial Universities Fundamental Research Funds Research Project","award":["2021-KYYWF-0599"],"award-info":[{"award-number":["2021-KYYWF-0599"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11262-024-02065-8","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T09:02:34Z","timestamp":1712134954000},"page":"243-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma"],"prefix":"10.1007","volume":"60","author":[{"given":"Xuemei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"2065_CR1","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/liv.15251","volume":"42","author":"CH Zhang","year":"2022","unstructured":"Zhang CH, Cheng Y, Zhang S, Fan J, Gao Q (2022) Changing epidemiology of hepatocellular carcinoma in Asia. Liver Int 42:2029\u20132041","journal-title":"Liver Int"},{"key":"2065_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res 149:1\u201361","journal-title":"Adv Cancer Res"},{"key":"2065_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 68:394\u2013424","journal-title":"CA A Cancer J Clin"},{"key":"2065_CR4","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/ijms20061358","volume":"20","author":"T Kanda","year":"2019","unstructured":"Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M (2019) Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. Int J Mol Sci 20:1358","journal-title":"Int J Mol Sci"},{"key":"2065_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB (2019) Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156:477-491.e471","journal-title":"Gastroenterology"},{"key":"2065_CR6","doi-asserted-by":"publisher","first-page":"100650","DOI":"10.1016\/j.aohep.2021.100650","volume":"27","author":"G Raimondo","year":"2022","unstructured":"Raimondo G, Rebello-Pinho JR, Panduro A (2022) Hepatitis B and C viruses and hepatocellular carcinoma. Annal Hepatol 27:100650","journal-title":"Annal Hepatol"},{"key":"2065_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","volume":"15","author":"P Konyn","year":"2021","unstructured":"Konyn P, Ahmed A, Kim D (2021) Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 15:1295\u20131307","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2065_CR8","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3390\/microorganisms9081787","volume":"9","author":"M Bousali","year":"2021","unstructured":"Bousali M, Papatheodoridis G, Paraskevis D, Karamitros T (2021) Hepatitis B virus DNA integration chronic infections and hepatocellular carcinoma. Microorganisms 9:1787","journal-title":"Microorganisms"},{"key":"2065_CR9","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.7150\/thno.34273","volume":"9","author":"J Feng","year":"2019","unstructured":"Feng J, Yang G, Liu Y, Gao Y, Zhao M, Bu Y, Yuan H, Yuan Y, Yun H, Sun M, Gao H, Zhang S, Liu Z, Yin M, Song X, Miao Z, Lin Z, Zhang X (2019) LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer. Theranostics 9:5227\u20135245","journal-title":"Theranostics"},{"key":"2065_CR10","doi-asserted-by":"publisher","first-page":"11593","DOI":"10.1038\/s41598-019-48116-1","volume":"9","author":"Q Liu","year":"2019","unstructured":"Liu Q, Liu N, Shangguan Q, Zhang F, Chai W, Tong X, Zhao X, Li Z, Qi D, Ye X (2019) LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1. Sci Rep 9:11593","journal-title":"Sci Rep"},{"key":"2065_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/CAD.0000000000001288","volume":"33","author":"W Fang","year":"2022","unstructured":"Fang W, Xia Y (2022) LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p\/PEG3 axis. Anticancer Drugs 33:671\u2013681","journal-title":"Anticancer Drugs"},{"key":"2065_CR12","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.lfs.2019.117180","volume":"254","author":"Y Huang","year":"2020","unstructured":"Huang Y, Sun H, Ma X, Zeng Y, Pan Y, Yu D, Liu Z, Xiang Y (2020) HLA-F-AS1\/miR-330-3p\/PFN1 axis promotes colorectal cancer progression. Life Sci 254:117180","journal-title":"Life Sci"},{"key":"2065_CR13","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41417-020-00276-3","volume":"28","author":"J Zhang","year":"2021","unstructured":"Zhang J, Li S, Zhang X, Li C, Zhang J, Zhou W (2021) LncRNA HLA-F-AS1 promotes colorectal cancer metastasis by inducing PFN1 in colorectal cancer-derived extracellular vesicles and mediating macrophage polarization. Cancer Gene Ther 28:1269\u20131284","journal-title":"Cancer Gene Ther"},{"key":"2065_CR14","first-page":"5021","volume":"20","author":"J Xu","year":"2019","unstructured":"Xu J, Zhang J, Shan F, Wen J, Wang Y (2019) SSTR5\u2011AS1 functions as a ceRNA to regulate CA2 by sponging miR\u201115b\u20115p for the development and prognosis of HBV\u2011related hepatocellular carcinoma. Mol Med Rep 20:5021\u20135031","journal-title":"Mol Med Rep"},{"key":"2065_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ng.2551","volume":"45","author":"T Hughes","year":"2013","unstructured":"Hughes T, Coit P, Adler A, Yilmaz V, Aksu K, D\u00fczg\u00fcn N, Keser G, Cefle A, Yazici A, Ergen A, Alpsoy E, Salvarani C, Casali B, K\u00f6tter I, Gutierrez-Achury J, Wijmenga C, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH (2013) Identification of multiple independent susceptibility loci in the HLA region in Beh\u00e7et\u2019s disease. Nat Genet 45:319\u2013324","journal-title":"Nat Genet"},{"key":"2065_CR16","doi-asserted-by":"publisher","first-page":"12289","DOI":"10.1080\/21655979.2022.2070965","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Zhu L, Luo Y (2022) Long non-coding RNA HLA-F antisense RNA 1 inhibits the maturation of microRNA-613 in polycystic ovary syndrome to promote ovarian granulosa cell proliferation and inhibit cell apoptosis. Bioengineered 13:12289\u201312297","journal-title":"Bioengineered"},{"key":"2065_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/1759-7714.12845","volume":"9","author":"Z Yang","year":"2018","unstructured":"Yang Z, Li H, Wang Z, Yang Y, Niu J, Liu Y, Sun Z, Yin C (2018) Microarray expression profile of long non\u2010coding RNAs in human lung adenocarcinoma. Thoracic cancer 9:1312\u20131322","journal-title":"Thoracic cancer"},{"key":"2065_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3892\/ol.2021.12801","volume":"22","author":"B Chen","year":"2021","unstructured":"Chen B, Yang M, Li K, Li J, Xu L, Xu F, Xu Y, Ren D, Zhang J, Liu L (2021) Immune\u2011related genes and gene sets for predicting the response to anti\u2011programmed death 1 therapy in patients with primary or metastatic non\u2011small cell lung cancer. Oncol Lett 22:540","journal-title":"Oncol Lett"},{"key":"2065_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/biology10050432","volume":"10","author":"Y Xu","year":"2021","unstructured":"Xu Y, Dong Y, Deng Y, Qi Q, Wu M, Liang H, She Q, Guo Q (2021) Identifying an lncRNA-related ceRNA network to reveal novel targets for a cutaneous squamous cell carcinoma. Biology 10:432","journal-title":"Biology"},{"key":"2065_CR20","doi-asserted-by":"publisher","first-page":"9139","DOI":"10.2147\/CMAR.S322351","volume":"13","author":"Y Wang","year":"2021","unstructured":"Wang Y, Xie T, Liu H, Yu X (2021) LncRNA HLA-F-AS1 enhances the migration, invasion and apoptosis of glioblastoma cells by targeting lncRNA MEG3. Cancer Manag Res 13:9139\u20139145","journal-title":"Cancer Manag Res"},{"key":"2065_CR21","doi-asserted-by":"publisher","first-page":"104722","DOI":"10.1016\/j.bioorg.2021.104722","volume":"109","author":"D Wu","year":"2021","unstructured":"Wu D, Jia H, Zhang Z, Li S (2021) STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD. Bioorg Chem 109:104722","journal-title":"Bioorg Chem"},{"key":"2065_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fgene.2019.00281","volume":"10","author":"YCS Ram\u00f3n","year":"2019","unstructured":"Ram\u00f3n YCS, Segura MF, H\u00fcmmer S (2019) Interplay between ncRNAs and cellular communication: a proposal for understanding cell-specific signaling pathways. Front Genet 10:281","journal-title":"Front Genet"},{"issue":"7","key":"2065_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/CAD.0000000000001288","volume":"33","author":"W Fang","year":"2022","unstructured":"Fang W, Xia Y (2022) LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p\/PEG3 axis. Anticancer Drugs 33(7):671\u2013681","journal-title":"Anticancer Drugs"},{"key":"2065_CR24","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1038\/s41388-019-1117-7","volume":"39","author":"R Zhong","year":"2020","unstructured":"Zhong R, Tian J, Fu M, Ma S, Liu L, Li J, Shen N, Ke J, Yang Y, Gong Y, Zhu Y, Wang Y, Gong J, Chang J, Lei P, Cheng X, Huang K, Shen G, Miao X (2020) LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk. Oncogene 39:1944\u20131956","journal-title":"Oncogene"},{"key":"2065_CR25","doi-asserted-by":"publisher","first-page":"101534","DOI":"10.1016\/j.tice.2021.101534","volume":"72","author":"Y Shi","year":"2021","unstructured":"Shi Y, Yan F, Wang F, Pan L (2021) MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Tissue Cell 72:101534","journal-title":"Tissue Cell"},{"key":"2065_CR26","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3892\/or.2015.3936","volume":"33","author":"CY Huang","year":"2015","unstructured":"Huang CY, Huang XP, Zhu JY, Chen ZG, Li XJ, Zhang XH, Huang S, He JB, Lian F, Zhao YN, Wu GB (2015) miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. Oncol Rep 33:2889\u20132898","journal-title":"Oncol Rep"},{"key":"2065_CR27","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.1038\/srep08534","volume":"5","author":"D Yu","year":"2015","unstructured":"Yu D, Green B, Marrone A, Guo Y, Kadlubar S, Lin D, Fuscoe J, Pogribny I, Ning B (2015) Sci Rep 5:8534","journal-title":"Sci Rep"},{"key":"2065_CR28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s42003-023-05017-4","volume":"6","author":"D Giosa","year":"2023","unstructured":"Giosa D, Lombardo D, Musolino C, Chines V, Raffa G, Casuscelli di Tocco F, D\u2019Aliberti D, Caminiti G, Saitta C, Alibrandi A, Aiese CR, Romeo O, Navarra G, Raimondo G, Pollicino T (2023) Mitochondrial DNA is a target of HBV integration. Commun Biol 6:684","journal-title":"Commun Biol"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-024-02065-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-024-02065-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-024-02065-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T11:13:55Z","timestamp":1717067635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-024-02065-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1007\/s11262-024-02065-8","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]},"assertion":[{"value":"28 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have completed the ICMJE uniform disclosure form. The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Human Research Ethics Committee of First Affiliated Hospital of Jiamusi University and informed consent was obtained from all individual participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}